Web Results


Rosen Law Firm, a global investor rights law firm, has filed a class action lawsuit on behalf of purchasers of Impax Laboratories, Inc. securities (NASDAQ: IPXL) ...


The latest litigation news involving the company Impax Laboratories, Inc. ( NASDAQ:IPXL)


May 18, 2018 ... Context for the Endo-Impax Litigation and Settlement . ...... re Amrep Corp., 102 F.T.C. 1362, 1670, 1983 FTC LEXIS 17, at *566-67 (Nov.


On March 28, 2018 Impax Laboratories Inc. reached a $20 million midtrial settlement with a class of End-Payors, ending this antitrust pay-for-delay lawsuit.


1”) is part of the prospectus of Amneal Pharmaceuticals, Inc. (the “Company”), dated May 9, 2018 (the “Prospectus”). ... period ended March 31, 2018, as filed with the Securities and Exchange Commission (“SEC”) on May ... (formerly IMPAX LABORATORIES, INC.) ...... In re Generic Pharmaceuticals Pricing Antitrust Litigation.


Mar 10, 2015 ... Impax Completes Acquisition Of Tower Holdings, Inc. And Lineage Therapeutics Inc. ... The Company intends to initiate a re-branding campaign in several ... "Safe Harbor" statement under the Private Securities Litigation ...


Sep 8, 2015 ... 8, 2015 /PRNewswire/ -- Impax Laboratories, Inc. (NASDAQ: IPXL) today ... The FDA notice follows a re-inspection in 2015 by the FDA of the Hayward facility. ... " Safe Harbor" statement under the Private Securities Litigation ...


Oct 1, 2016 ... Securities registered pursuant to Section 12(b) of the Act: ..... Acquisition Agreement”) with Teva Pharmaceuticals USA, Inc. (“Teva”) pursuant to which we acquired the ...... In re Generic Digoxin and Doxycycline Class Action.


Oct 31, 2017 ... The case stems from an action brand manufacturer Endo Pharmaceuticals, Inc. ( Endo) brought against Impax Laboratories, Inc. (Impax) and ...